Floatz logo

Cyclophosphamide

Malignant Germ Cell Tumor

St. Jude Children's Research HospitalSmall moleculePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

24 Active assets in the Malignant Germ Cell Tumor cohort.

Asset / SponsorPhaseRating
Carboplatin
Children's Oncology Group
Phase 3BB
ETOPOSIDE
Children's Oncology Group
Phase 3BB
Eloxatin
National Cancer Institute (NCI)
Phase 2BB
FILGRASTIM
Children's Oncology Group
Phase 2B
BLEOMYCIN
Children's Oncology Group
Phase 3B

View all 35 →

Same molecule, other indications

Cyclophosphamide is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →